Global Androgen Suppression Therapy Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04252508

Publication Date:

April 25, 2025

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Androgen Suppression Therapy market size is predicted to grow from US$ 12110 million in 2025 to US$ 16600 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
Androgen suppression therapy (ADT), also known as hormone therapy, is a medical treatment that lowers the levels of male hormones, called androgens (primarily testosterone). It"s primarily used for treating prostate cancer and sometimes other conditions that are affected by androgens.
The Androgen Suppression Therapy (ADT) market is expected to see steady growth in the coming years, driven by several key factors:
Market Drivers:
Rising incidence of prostate cancer: Prostate cancer is the most common cancer among men worldwide, and Androgen Suppression Therapy remains a cornerstone treatment option, fueling market demand.
Aging population: With an increasing aging population, the prevalence of prostate cancer and other conditions treated with Androgen Suppression Therapy is expected to rise, further propelling market growth.
Evolving treatment protocols: Advancements in medical research are leading to new and personalized approaches to Androgen Suppression Therapy, including shorter treatment durations and combination therapies, expanding market options.
Increasing awareness and access to treatment: Growing awareness about prostate cancer and its treatment options, coupled with improved healthcare access in some regions, is driving higher uptake of Androgen Suppression Therapy.
Development of novel formulations and delivery systems: Advancements in drug delivery, like long-acting injectable medications and oral medications with fewer side effects, are improving patient compliance and potentially expanding the market reach.
Challenges and Future Outlook:
Cost-effectiveness concerns: Androgen Suppression Therapy can be expensive, and rising healthcare costs could limit accessibility for patients in some regions.
Side effects and long-term health impacts: The potential side effects of Androgen Suppression Therapy, including bone loss and cardiovascular risks, require ongoing research and development of safer and more effective treatment options.
Patient compliance: Addressing concerns about side effects and ensuring adherence to treatment protocols remain crucial for achieving optimal treatment outcomes.
Despite these challenges, the Androgen Suppression Therapy market holds promising potential for sustained growth. Continued research into novel therapies, improved access to treatment, and developing personalized treatment plans will be key factors in shaping the future of this market.
The 鈥淎ndrogen Suppression Therapy Industry Forecast鈥� looks at past sales and reviews total world Androgen Suppression Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Androgen Suppression Therapy sales for 2025 through 2031. With Androgen Suppression Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Androgen Suppression Therapy industry.
This Insight Report provides a comprehensive analysis of the global Androgen Suppression Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Androgen Suppression Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Androgen Suppression Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Androgen Suppression Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Androgen Suppression Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Androgen Suppression Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Tablet
Injection
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Astellas
Johnson & Johnson
AstraZeneca
Bayer
Merck
Tolmar
Zoladex
Ferring Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
CTTQ

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Androgen Suppression Therapy Market Size (2020-2031)
2.1.2 Androgen Suppression Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Androgen Suppression Therapy by Country/Region (2020, 2024 & 2031)
2.2 Androgen Suppression Therapy Segment by Type
2.2.1 Tablet
2.2.2 Injection
2.3 Androgen Suppression Therapy Market Size by Type
2.3.1 Androgen Suppression Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Androgen Suppression Therapy Market Size Market Share by Type (2020-2025)
2.4 Androgen Suppression Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Androgen Suppression Therapy Market Size by Application
2.5.1 Androgen Suppression Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Androgen Suppression Therapy Market Size Market Share by Application (2020-2025)
3 Androgen Suppression Therapy Market Size by Player
3.1 Androgen Suppression Therapy Market Size Market Share by Player
3.1.1 Global Androgen Suppression Therapy Revenue by Player (2020-2025)
3.1.2 Global Androgen Suppression Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Androgen Suppression Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Androgen Suppression Therapy by Region
4.1 Androgen Suppression Therapy Market Size by Region (2020-2025)
4.2 Global Androgen Suppression Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Androgen Suppression Therapy Market Size Growth (2020-2025)
4.4 APAC Androgen Suppression Therapy Market Size Growth (2020-2025)
4.5 Europe Androgen Suppression Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Androgen Suppression Therapy Market Size Growth (2020-2025)
5 Americas
5.1 Americas Androgen Suppression Therapy Market Size by Country (2020-2025)
5.2 Americas Androgen Suppression Therapy Market Size by Type (2020-2025)
5.3 Americas Androgen Suppression Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androgen Suppression Therapy Market Size by Region (2020-2025)
6.2 APAC Androgen Suppression Therapy Market Size by Type (2020-2025)
6.3 APAC Androgen Suppression Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Androgen Suppression Therapy Market Size by Country (2020-2025)
7.2 Europe Androgen Suppression Therapy Market Size by Type (2020-2025)
7.3 Europe Androgen Suppression Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Androgen Suppression Therapy by Region (2020-2025)
8.2 Middle East & Africa Androgen Suppression Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Androgen Suppression Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Androgen Suppression Therapy Market Forecast
10.1 Global Androgen Suppression Therapy Forecast by Region (2026-2031)
10.1.1 Global Androgen Suppression Therapy Forecast by Region (2026-2031)
10.1.2 Americas Androgen Suppression Therapy Forecast
10.1.3 APAC Androgen Suppression Therapy Forecast
10.1.4 Europe Androgen Suppression Therapy Forecast
10.1.5 Middle East & Africa Androgen Suppression Therapy Forecast
10.2 Americas Androgen Suppression Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Androgen Suppression Therapy Forecast
10.2.2 Canada Market Androgen Suppression Therapy Forecast
10.2.3 Mexico Market Androgen Suppression Therapy Forecast
10.2.4 Brazil Market Androgen Suppression Therapy Forecast
10.3 APAC Androgen Suppression Therapy Forecast by Region (2026-2031)
10.3.1 China Androgen Suppression Therapy Market Forecast
10.3.2 Japan Market Androgen Suppression Therapy Forecast
10.3.3 Korea Market Androgen Suppression Therapy Forecast
10.3.4 Southeast Asia Market Androgen Suppression Therapy Forecast
10.3.5 India Market Androgen Suppression Therapy Forecast
10.3.6 Australia Market Androgen Suppression Therapy Forecast
10.4 Europe Androgen Suppression Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Androgen Suppression Therapy Forecast
10.4.2 France Market Androgen Suppression Therapy Forecast
10.4.3 UK Market Androgen Suppression Therapy Forecast
10.4.4 Italy Market Androgen Suppression Therapy Forecast
10.4.5 Russia Market Androgen Suppression Therapy Forecast
10.5 Middle East & Africa Androgen Suppression Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Androgen Suppression Therapy Forecast
10.5.2 South Africa Market Androgen Suppression Therapy Forecast
10.5.3 Israel Market Androgen Suppression Therapy Forecast
10.5.4 Turkey Market Androgen Suppression Therapy Forecast
10.6 Global Androgen Suppression Therapy Forecast by Type (2026-2031)
10.7 Global Androgen Suppression Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Androgen Suppression Therapy Forecast
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Androgen Suppression Therapy Product Offered
11.1.3 Pfizer Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Astellas
11.2.1 Astellas Company Information
11.2.2 Astellas Androgen Suppression Therapy Product Offered
11.2.3 Astellas Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Astellas Main Business Overview
11.2.5 Astellas Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Androgen Suppression Therapy Product Offered
11.3.3 Johnson & Johnson Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Androgen Suppression Therapy Product Offered
11.4.3 AstraZeneca Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Androgen Suppression Therapy Product Offered
11.5.3 Bayer Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Androgen Suppression Therapy Product Offered
11.6.3 Merck Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Tolmar
11.7.1 Tolmar Company Information
11.7.2 Tolmar Androgen Suppression Therapy Product Offered
11.7.3 Tolmar Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Tolmar Main Business Overview
11.7.5 Tolmar Latest Developments
11.8 Zoladex
11.8.1 Zoladex Company Information
11.8.2 Zoladex Androgen Suppression Therapy Product Offered
11.8.3 Zoladex Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Zoladex Main Business Overview
11.8.5 Zoladex Latest Developments
11.9 Ferring Pharmaceuticals
11.9.1 Ferring Pharmaceuticals Company Information
11.9.2 Ferring Pharmaceuticals Androgen Suppression Therapy Product Offered
11.9.3 Ferring Pharmaceuticals Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Ferring Pharmaceuticals Main Business Overview
11.9.5 Ferring Pharmaceuticals Latest Developments
11.10 Jiangsu Hengrui Pharmaceuticals
11.10.1 Jiangsu Hengrui Pharmaceuticals Company Information
11.10.2 Jiangsu Hengrui Pharmaceuticals Androgen Suppression Therapy Product Offered
11.10.3 Jiangsu Hengrui Pharmaceuticals Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
11.10.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
11.11 CTTQ
11.11.1 CTTQ Company Information
11.11.2 CTTQ Androgen Suppression Therapy Product Offered
11.11.3 CTTQ Androgen Suppression Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 CTTQ Main Business Overview
11.11.5 CTTQ Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂